Cyanotic heart defect medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.; Kalsang Dolma, M.B.B.S.[3]

Overview

Medical Therapy

Infants that remain in the hospital may receive medicines to:

Get rid of extra fluids
Help the heart pump harder
Treat abnormal heartbeats or rhythms
Prostaglandin E1 (alprostadil) — Administered in infants with clinical suspicion of ductal-dependent congenital heart defect until a definitive diagnosis or treatment is established.

References

Overview